Mitchell, James B.
National Cancer Institute (NCI),
United States
2025 Rank: 153285
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 4665 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 153285 | 171073 |
| Total Cites | 958 | 1037 |
| H-index | 13 | 13 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 44 | 47 |
| Number of Single+First+Last Authored Papers | 173 | 173 |
| Total Cites to Single+First+Last Authored Papers | 363 | 377 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 803 | 833 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.24 |
| Self-Citation Percentage |
7.62%
|
|
Mitchell, James B.
National Institutes of Health (NIH),
United States
2024 Rank: 131372
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 4280 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 131372 | 133195 |
| Total Cites | 1013 | 1100 |
| H-index | 13 | 14 |
| Hm-index | 5 | 5 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 62 | 62 |
| Number of Single+First+Last Authored Papers | 174 | 174 |
| Total Cites to Single+First+Last Authored Papers | 400 | 414 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 866 | 889 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.24 |
| Self-Citation Percentage |
7.91%
|
|
Mitchell, James B.
National Cancer Institute (NCI),
United States
2023 Rank: 114027
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 4054 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 114027 | 116372 |
| Total Cites | 1148 | 1290 |
| H-index | 15 | 15 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 48 | 55 |
| Number of Single+First+Last Authored Papers | 173 | 173 |
| Total Cites to Single+First+Last Authored Papers | 438 | 471 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 954 | 1002 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.29 |
| Self-Citation Percentage |
11.01%
|
|
Mitchell, James B.
National Cancer Institute (NCI),
United States
2022 Rank: 85491
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 3248 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85491 | 88976 |
| Total Cites | 1306 | 1453 |
| H-index | 15 | 16 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 66 | 69 |
| Number of Single+First+Last Authored Papers | 171 | 171 |
| Total Cites to Single+First+Last Authored Papers | 505 | 538 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1100 | 1160 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.25 |
| Self-Citation Percentage |
10.12%
|
|
Mitchell, James B.
National Cancer Institute (NCI),
United States
2021 Rank: 86703
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 3115 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 86703 | 95582 |
| Total Cites | 1963 | 2128 |
| H-index | 18 | 19 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 104 | 109 |
| Number of Single+First+Last Authored Papers | 168 | 168 |
| Total Cites to Single+First+Last Authored Papers | 834 | 870 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1688 | 1773 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.20 |
| Self-Citation Percentage |
7.75%
|
|
Mitchell, James B.
National Cancer Institute,
United States
2020 Rank: 60418
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 2102 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60418 | 67584 |
| Total Cites | 1620 | 1790 |
| H-index | 16 | 17 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 3 | 3 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 117 | 120 |
| Number of Single+First+Last Authored Papers | 170 | 170 |
| Total Cites to Single+First+Last Authored Papers | 756 | 783 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1345 | 1422 |
| Ratio of Total Citations to Distinct Citing Papers | 1.20 | 1.26 |
| Self-Citation Percentage |
9.50%
|
|